Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation

Biologics: Targets and Therapy

Volumn 2, Issue 4, 2008, Pages 845-854

  Kumar, Raj ^a   Calhoun, William J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Coactivators; Gene regulation; Glucocorticoid receptor; Phosphorylation; Transactivation activity

Indexed keywords

EID: 77952664545     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: 10.2147/btt.s3820     Document Type: Review

References (112)

1. Almlof T, Wright AP, Gustafsson JA. 1995. Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor, J Biol Chem, 270:17535-40.
2. Auricchio F. 1989. Phosphorylation of steroid receptors. J Steroid Biochem, 32:613-22.
3. Bai W, Weigel NL. 1995. Phosphorylation and steroid hormone action. Vit Hormones, 51:289-313.
4. Baskakov IV, Kumar R, Srinivasan G, et al. 1999. Trimethylamine N-Oxide-induced cooperative folding of an intrinsically unfolded transcription-activating fragment of human glucocorticoid receptor. J Biol Chem, 274:10693-6.
5. Beato M. 1989. Gene regulation by steroid hormones. Cell, 56:335-4.
6. Bledsoe RK, Montana VG, Stanley TB, et al. 2002. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell, 110:93-105.
7. Blind RD, Garabedian MJ. 2004. Regulation of glucocorticoid receptormediated transcriptional activation: The role of receptor phosphorylation and cofactor recruitment. Abstract Book, KeyStone Symposia on Nuclear Receptors.
8. Blind RD, Garabedian MJ. 2008. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J Steroid Biochem Mol Biol, 109:150-7.
9. Bocquel MT, Kumar V, Stricker C, et al. 1989. The contribution of the N-and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res, 17:2581-95.
10. Bodwell JE, Webster JC, Jewell CM, et al. 1998. Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J Steroid Biochem Mol Biol, 65:91-9.
11. Bodwell JE, Orti E, Coull JM, et al. 1991. Identification of phosphorylated sites in the mouse glucocorticoid receptor. J Biol Chem, 266:7549-55.
12. Bommer M, Benecke A, Gronemeyer H. 2002. TIF2 mediates the synergy between RARb1 activation functions AF-1 and AF-2. J Biol Chem, 277:37961-6.
13. Boyle WJ, Smeal T, Defize LHK, et al. 1991. Activation of protein kinas C decreases phosphorylation of c-jun at sites that negatively regulate its DNA-binding activity. Cell, 64:573-84.
14. Chauchereau A, Amazit L, Quesne M. 2003. Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J Biol Chem, 278:12335-43.
15. Chen H, Lin RJ, Xie W, et al. 1999. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell, 98:675-86.
16. Chen W, Dang T, Blind RD, et al. 2008. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol, 2008 May 15. [Epub ahead of print].
17. Chevillard-Briet M, Trouche D, Vandel L. 2002. Control of CBP co-activating activity by arginine methylation. EMBO J, 21:5457-66.
18. Crivici A, Ikura M. 1995. Molecular and structural basis of target recognition by calmodulin. Annu Rev Biophys Biomol Struct, 24:85-116.
19. Dahlman-Wright K, Baumann H, McEwan IJ, et al. 1995. Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc Natl Acad Sci U S A, 92:1699-703.
20. Davies TH, Ning YM, Sánchez ER. 2002. A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem, 277:4597-600.
21. Davies L, Karthikeyan N, Lynch JT, et al. 2008. Crosstalk of signaling pathways in the regulation of the glucocorticoid receptor function. Mol Endocrinol, 22:1331-44.
22. Dean DM, Sanders MM. 1996. Ten years after: reclassification of steroidresponsive genes. Mol Endocrinol, 10:1489-95.
23. DeFranco DB, Qi M, Borror KC, et al. 1991. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol Endocrinol, 5:1215-28.
24. Duma D, Jewell CM, Cidlowski JA. 2006. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol, 102:11-21.
25. Dyson HJ, Wright PE. 2002. Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol, 12:54-60.
26. Evans RM. 1988. The steroid and thyroid hormone receptor superfamily. Science, 240:889-5.
27. Faus H, Haendler B. 2006. Post-translational modifications of steroid receptors. Biomed Pharmacother, 60:520-8.
28. Font de Mora J, Brown M. 2000. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol, 20:5041-7.
29. Fujita T, Kobayashi Y, Wada O, et al. 2003. Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells. J Biol Chem, 278:26704-14.
30. Giguere V, Hollenberg SM, Rosenfeld MG. 1986. Functional domains of the human glucocorticoid receptor. Cell, 46:545-52.
31. Gioeli D, Ficarro SB, Kwiek JJ, et al. 2002. Androgen receptor phosphorylation. J Biol Chem, 32:29304-14.
32. Glass CK, Rose DW, Rosenfeld MG. 1997. Nuclear receptor coactivators. Curr Opin Cell Biol, 9:222-32.
33. Godowski PJ, Rusconi S, Miesfeld R, et al. 1987. Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature, 325:365-8.
34. Hard T, Kellenbach E, Boelens R, et al. 1990. Solution structure of the DNA binding domain of the glucocorticoid receptor. Science, 249:157-60.
35. Henriksson A, Almlof T, Ford J, et al. 1997. Role of Ada adapter complex in gene activation by the glucocorticoid receptor. Mol Cell Biol, 17:3065-73.
36. Hittelman AB, Burakov D, Iniguez-Lluhi JA. 1999. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J, 18:5380-8.
37. Hollenberg SM, Giguere V, Segui P, et al. 1987. Colocalization of DNAbinding and transcriptional activation functions in the human glucocorticoid receptor. Cell, 49:39-46.
38. Horwitz KB, Jackson TA, Bain DL, et al. 1996. Nuclear receptor coactivators and corepressors. Mol Endocrinol, 10:1167-77.
39. Housley PR, Sanchez ER, Westphal HM, et al. 1985. The molybdatestabilized L-cell glucocorticoid receptor isolated by affinity chromatography or with a monoclonal antibody is associated with a 90-92-kDa nonsteroid-binding phosphoprotein. J Biol Chem, 260:13810-17.
40. Iakoucheva LM, Brown CJ, Lawson JD, et al. 2002. Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol, 323:573-84.
41. Ikonen T, Palvimo JJ, Janne OA. 1997. Interaction between the amino-and carboxy-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem, 272:29821-8.
42. Ismaili N, Garabedian MJ. 2004. Modulation of glucocorticoid receptor function via phosphorylation. Ann NY Acad Sci, 1024:86-101.
43. Ismaili N, Blind R, Garabedian MJ. 2005. Stabilization of the unliganded glucocorticoid receptor by TSG101. J Biol Chem, 280:11120-6.
44. Ito K, Yamamura S, Essilfie-Quaye S, et al. 2006. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med, 203:7-13.
45. King KL, Cidlowski JA. 1998. Cell cycle regulation and apoptosis. Annu Rev Physiol, 60:601-17.
46. Kino T, Ichijo T, Amin ND, et al. 2007. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: Clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol, 21:1552-68.
47. Kinyamu HK, Chen J, Archer TK. 2005. Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors, J Mol Endocrinol, 34:281-97.
48. Kotaja N, Karvonen U, Janne OA, et al. 2002. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem, 277:30283-8.
49. Krstic MD, Rogatsky I, Yamamoto KR, et al. 1997. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor, Mol Cell Biol, 17:3947-54.
50. Kuiper G, Brinkmann AO. 1994. Steroid hormone receptor phosphorylation: is there a physiological role? Mol Cell Endocrinol, 100:103-7.
51. Kumar R, Thompson EB. 1999a. Structure and functions of the nuclear hormone receptors. Steroids, 64:310-19.
52. Kumar R, Baskakov IV, Srinivasan G, et al. 1999b. Interdomain signaling in a two-domain fragment of human glucocorticoid receptor. J Biol Chem, 274:24737-41.
53. Kumar R, Thompson EB. 2003. Transactivation functions of the N-terminal domains of nuclear hormone receptors: Protein folding and coactivator interactions. Mol Endocrinol, 17:1-10.
54. Kumar R, Johnson BH, Thompson EB. 2004a. Overview of the structural basis for transcription regulation by nuclear hormone receptors. Essay Biochem, 40:27-39.
55. Kumar R, Volk DE, Li J, et al. 2004b. TBP binding induces structure in the recombinant glucocorticoid receptor AF1 domain. Proc Natl Acad Sci U S A, 101:16425-30.
56. Le Drean Y, Mincheneau N, Le Goff P, et al. 2002. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology, 143:3482-9.
57. Lefstin JA, Yamamoto KR. 1998. Allosteric effects of DNA on transcriptional regulators. Nature, 392:885-8.
58. Liu J, Perumal NB, Oldfield CJ, et al. 2006. Intrinsic disorder in transcription factors. Biochem, 45:6873-88.
59. Luisi BF, Xu WX, Otwinowski Z, et al. 1991. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature, 352:497-505.
60. Lopez GN, Turck CW, Schaufele F, et al. 2001. Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J Biol Chem, 276:22177-82.
61. Loven AM, Muster N, Yates JR, et al. 2003. A novel estrogen receptor alphaassociated protein, template-activating factor Ibeta, inhibits acetylation and transactivation. Mol Endocrinol, 17:67-78.
62. Mason SA, Housley PR. 1993. Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor, J Biol Chem, 268:21501-4.
63. McKenna NJ, Lanz RB, O'Malley BW. 1999. Nuclear receptor coregulators: cellular and molecular biology. Endocrine Rev, 20:321-44.
64. Mendelson CR. 2004. Mechanism of hormone action. In: Griffin JE, Ojeda SR (Eds). Text Book of Endocrine Physiology (5th ed). New York: Oxford University Press, pp. 49-88.
65. Metivier R, Penot G, Flouriot G. 2001. Synergism between ERMMtransactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 1-helical core and for a direct interaction between the N-and C-terminal domains. Mol Endocrinol, 15:1953-70.
66. Miesfeld R, Godowski PJ, Maler BA, et al. 1987. Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. Science, 236:423-7.
67. Milller AL, Webb MS, Copik AJ, et al. 2005. p38 MAP kinase is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: Correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol, 19:1569-83.
68. Morishima Y, Kanelakis KC, Murphy PJM, et al. 2003. The Hsp90 cochaperone p23 is the limiting component of the multiprotein Hsp90/ Hsp70-based chaperone system in vivo where it acts to stabilize the client protein Hsp90 complex, J Biol Chem, 278:48754-63.
69. Namba K. 2001. Roles of partly unfolded conformations in macromolecular self-assembly. Genes Cells, 6:1-12.
70. Nichols M, Weih F, Schmid W, et al. 1992. Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription. EMBO J, 11:3337-46.
71. Nissen RM, Yamamoto KR. 2000. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain, Genes Dev, 14:2314-29.
72. Orti E, Bodwell JE, Munck A. 1992. Phosphorylation of steroid hormone receptors. Endocri Rev, 13:105-28.
73. Orti E, Mendel DB, Smith LI, et al. 1989. A dynamic model for glucocorticoid receptor phosphorylation and cycling in insect cells. J Steroid Biochem, 34:85-96.
74. Pinhero R, Liaw P, Bertens K. 2004. Three cyclin-dependent kinases preferentially phosphorylate different parts of C-terminal domain of the large subunit of RNA polymerase II. Euro J Biochem, 271:1004-14.
75. Pratt WB, Toft DO. 1997. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endo Rev, 18:306-60.
76. Pratt WB, Toft DO. 2003. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery, Exp Biol Med, 228:111-33.
77. Puigserver P, Rhee J, Lin J, et al. 2001. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPAReecoactivator-1. Mol Cell, 8:971-82.
78. Rogatsky I, Wang JC, Derynck MK, et al. 2003. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor, Proc Natl Acad Sci U S A, 100:13845-50.
79. Rogatsky I, Waase CL, Garabedian MJ. 1998a. Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation. J Biol Chem, 273:14315-21.
80. Rogatsky I, Logan SK, Garabedian MJ. 1998b. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc Natl Acad Sci U S A, 95:2050-5.
81. Rogatsky I, Trowbridge JM, Garabedian MJ. 1997. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol, 17:3181-93.
82. Romero P, Obradovic Z, Dunker AK. 2004. Natively disordered proteins: functions and predictions. Appl Bioinformatics, 3:105-13.
83. Rowan BG, Weigel NL, O'Malley BW. 2000a. Phosphorylation of steroid receptor coactivator-1. Identification of phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem, 275:4475-83.
84. Rowan BG, Garrison N, Weigel NL, et al. 2000b. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol Cell Biol, 20:8720-30.
85. Sanchez ER, Meshinchi S, Tienrungroz W, et al. 1987. Relationship of the 90 kDa murine heat shock protein with the untransformed and transformed states of the cell glucocorticoid receptor. J Biol Chem, 262:6986-91.
86. See RH, Calvo D, Shi Y, et al. 2001. Stimulation of p300-mediated transcription by the kinase MEKK1. J Biol Chem, 276:16310-7.
87. Shikama N, Chan HM, Krstic-Demonacos M, et al. 2000. Functional interaction between nucleosome assembly proteins and p300/CREBbinding protein family coactivators, Mol Cell Biol, 20:8933-43.
88. Silverstein AM, Galigniana MD, Kanelakis KC, et al. 1999. Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein. J Biol Chem, 274:36980-6.
89. Simons SS Jr. 1994. Function/activity of specific amino acids in glucocorticoid receptors. In: Litwack G (ed). Vitamins and Hormones Volume 49: Steroids. New York: Academic Press, pp. 49-130.
90. Somers JP, DeFranco DB. 1992. Effects of okadaic acid, a protein phosphatase inhibitor, on glucocorticoid receptor-mediated enhancement. Mol Endocrinol, 6:26-34.
91. Starr DB, Matsui W, Thomas JR, et al. 1996. Intracellular receptors use a common mechanism to interpret signaling information at response elements. Genes Devel, 10:1271-83.
92. Szatmary Z, Garabedian MJ, Vilcek J. 2004. Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J Biol Chem, 279:43708-15.
93. Tetel MJ, Giangrande PH, Leonhardt SA, et al. 1999. Hormone-dependent interaction between the amino-and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol Endocrinol, 13:910-24.
94. Thompson EB, Kumar R. 2003. DNA binding of nuclear hormone receptors influences their structure and function. Biochem Biophys Res Commun, 306:1-4.
95. Tian S, Poukka H, Palvimo JJ, et al. 2002. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem J, 367:907-11.
96. Tompa P. 2002. Intrinsically unstructured proteins. Trends Biochem Sci, 27:527-33.
97. Tzukerman MT, Esty A, Santiso-Mere D. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol, 8:21-30.
98. Wallace AD, Cidlowski JA. 2001. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem, 276:42714-21.
99. Wang LG, Liu MX, Kreis W, et al. 1999. Phosphorylation/dephosphorylation of androgen as a determinant of androgen agonistic or antagonistic activity. Biochem Biophys Res Commun, 259:21-8.
100. Wang Z, Chen W, Kono E, et al. 2007. Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase. Mol Endocrinol, 21:625-34.
101. Wang Z, Frederick J, Garabedian MJ. 2002. Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. J Biol Chem, 277:26573-80.
102. Ward JJ, Sodhi JS, McGuffin LJ, et al. 2004. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol, 337:635-45.
103. Webster JC, Jewell CM, Bodwell JE, et al. 1997. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem, 272:9287-93.
104. Weigel NL, Moore NL. 2007a. Kinases and protein phosphorylation as regulators of steroid hormone action. Nucl Recept Signal, 5:e005.
105. Weigel NL, Moore NL. 2007b. Cyclins, cyclin dependent kinases, and regulation of steroid receptor action. Mol Cell Endocrinol, 265-66:157-61.
106. Wisniewski JR, Szewczuk Z, Petry I, et al. 1999. Constitutive phosphorylation of the acidic tails of the high mobility group 1 proteins by casein kinase II alters their conformation, stability, and DNA binding specificity. J Biol Chem, 274:20116-22.
107. Wu RC, Smith CL, O'Malley BW. 2005. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr Rev, 26:393-9.
108. Wu RC, Qin J, Yi P, et al. 2004. Selective phosphorylations of the SRC-3/ AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell, 15:937-49.
109. Yamamoto KR. 1985. Steroid receptor regulated transcription of specific genes and gene network. Annu Rev Genet, 19:209-52.
110. Yamamoto KR, Darimont BD, Wagner RL, et al. 1998. Building transcriptional regulatory complexes: signals and surfaces. Cold Spring Harb Symp Quant Biol, 63:5875-98.
111. Yang W, Hong YH, Shen XQ, et al. 2001. Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors. J Biol Chem, 276:38341-4.
112. Zhou J, Cidlowski JA. 2005. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids, 70:407-17.